ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO184

Association between Decrease in Skeletal Muscle Mass Index and Renal Atrophy in Patients with Non-Dialysis CKD

Session Information

Category: Nutrition, Inflammation, and Metabolism

  • 1401 Nutrition, Inflammation, Metabolism

Authors

  • Iio, Rei, Osaka General Medical Center, Osaka, Japan
  • Kumamoto, Rika, Osaka General Medical Center, Osaka, Japan
  • Takatsuka, Taisuke, Osaka General Medical Center, Osaka, Japan
  • Yoshimura, Daisuke, Osaka General Medical Center, Osaka, Japan
  • Okushima, Hiroki, Osaka General Medical Center, Osaka, Japan
  • Iwata, Yukimasa, Osaka General Medical Center, Osaka, Japan
  • Kensuke, Mitsumoto, Osaka General Medical Center, Osaka, Japan
  • Shoji, Tatsuya, Osaka General Medical Center, Osaka, Japan
  • Hayashi, Terumasa, Osaka General Medical Center, Osaka, Japan
Background

The frequency of sarcopenia increases as chronic kidney disease (CKD) progresses. CKD patients should be screened for sarcopenia and presarcopenia in order to detect them during an earlier stage of CKD and improve prognosis. Kidney size is associated with aging, inflammation, and decreased renal function, as seen with sarcopenia. We investigated the association of kidney size with muscle mass and muscle mass change in CKD patients.

Methods

We performed a single-center retrospective cohort study of 180 non-dialysis dependent CKD patients (age 66.4±12.5 years; male 66.1%; eGFR 31.4±17.5 mL/min/1.73m2; etiology glomerulonephritis 22.2%, diabetic nephropathy 23.9%). We measured kidney size by ultrasonography and calculated total kidney volume (TKV) using an ellipsoid equation. Skeletal muscle mass index (SMI) were estimated using bioelectrical impedance analysis, and presarcopenia was defined as SMI ≤7.0 kg/m2 for men and ≤5.7 kg/m2 for women. The rate of change in SMI over a 6-month period was evaluated.

Results

The mean rate of change in SMI in six months was -1.5±7.1%. Multivariate logistic regression analysis showed that TKV was associated with presarcopenia (OR: 0.98, 95% confidential interval: 0.97-1.00, p=0.041). Multivariate regression analysis showed that SMI (β: -3.95, SE: 0.92, p<0.001) and TKV (β: 0.037, SE: 0.015, p=0.016) were associated with the rate of change of SMI in six months adjusted for age, sex, BMI, diabetes mellitus, history of cardiovascular disease, serum albumin, and proteinuria.

Conclusion

Among patients with CKD, presarcopenia is significantly associated with TKV, and patients with a small TKV are more prone to developing a decrease in skeletal muscle mass.